Lumenis Acquired, Nasdaq: LMNS
Sells laser-based systems used in surgical, ophthalmic and aesthetic procedures.
Industry: Health Care
First Day Return: +1.3%
LMNS
Sells laser-based systems used in surgical, ophthalmic and aesthetic procedures.
| IPO Data | |
|---|---|
| IPO Date | 02/26/2014 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $75 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Yokneam, Israel |
| Founded | 1991 |
| Employees at IPO | 1,061 |
| Website www.lumenis.com | |
IPO News for Lumenis
Lumenis (LMNS) Performance
